New Water-Soluble Polymeric Prodrugs of 2-n-propylquinoline: Synthesis and Evaluation of In Vitro and In Vivo Activities Against Leishmania donovani

[1]  A. Jayakrishnan,et al.  Synthetic Polysaccharides as Drug Carriers: Synthesis of Polyglucose-Amphotericin B Conjugates and In Vitro Evaluation of Their Anti-Fungal and Anti-Leishmanial Activities. , 2018, Journal of nanoscience and nanotechnology.

[2]  A. Jayakrishnan,et al.  Anti-fungal and anti-leishmanial activities of pectin-amphotericin B conjugates , 2017 .

[3]  J. Vacus,et al.  In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  A. Domb,et al.  Polysaccharide-Based Conjugates for Biomedical Applications. , 2015, Bioconjugate chemistry.

[5]  S. Puri,et al.  Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogs. , 2014, Bioorganic & medicinal chemistry letters.

[6]  S. Mohapatra.  Drug resistance in leishmaniasis: Newer developments , 2014, Tropical parasitology.

[7]  S. Puri,et al.  Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents. , 2013, European journal of medicinal chemistry.

[8]  M. Vicent,et al.  Polymer therapeutics-prospects for 21st century: the end of the beginning. , 2013, Advanced drug delivery reviews.

[9]  J. Le bras,et al.  Leishmania Resistance to Miltefosine Associated with Genetic Marker , 2012, Emerging infectious diseases.

[10]  Hamidreza Ghandehari,et al.  Polymeric conjugates for drug delivery. , 2012, Chemistry of materials : a publication of the American Chemical Society.

[11]  D. Singh,et al.  Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani , 2011, Antimicrobial Agents and Chemotherapy.

[12]  J. Vacus,et al.  Antileishmanial activity of a formulation of 2-n-propylquinoline by oral route in mice model , 2011, Parasite.

[13]  J. Vacus,et al.  Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  A. Domb,et al.  Polysaccharides as carriers of bioactive agents for medical applications , 2008 .

[15]  J. Desrivot,et al.  In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  P. Loiseau,et al.  Amphotericin B-Gum Arabic Conjugates: Synthesis, Toxicity, Bioavailability, and Activities Against Leishmania and Fungi , 2007, Pharmaceutical Research.

[17]  A. Rojas de Arias,et al.  Efficacy of Orally Administered 2-Substituted Quinolines in Experimental Murine Cutaneous and Visceral Leishmaniases , 2005, Antimicrobial Agents and Chemotherapy.

[18]  N. Heindel,et al.  Determination of Degree of Substitution of Formyl Groups in Polyaldehyde Dextran by the Hydroxylamine Hydrochloride Method , 1991, Pharmaceutical Research.

[19]  J. Mouscadet,et al.  Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections. , 2003, Bioorganic & medicinal chemistry.

[20]  S. Croft,et al.  Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). , 2003, International journal of antimicrobial agents.

[21]  A. Domb,et al.  A Novel Injectable Water-Soluble Amphotericin B-Arabinogalactan Conjugate , 1999, Antimicrobial Agents and Chemotherapy.

[22]  R. Farinotti,et al.  Determination of 2-n-propylquinoline in mouse plasma and liver by high-performance liquid chromatography. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[23]  P. Loiseau,et al.  Mechanism of Amphotericin B Resistance inLeishmania donovani Promastigotes , 1998, Antimicrobial Agents and Chemotherapy.

[24]  A. Rojas de Arias,et al.  In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis , 1996, Antimicrobial agents and chemotherapy.

[25]  V. Muñoz,et al.  2-substituted quinoline alkaloids as potential antileishmanial drugs , 1993, Antimicrobial Agents and Chemotherapy.

[26]  P. Mora,et al.  Synthetic Polysaccharides. I. Polycondensation of Glucose1 , 1958 .